The Big Ones 2020 has been a year when, for obvious reasons, innovative drug development has taken a leap forward. Tempus combines artificial intelligence and…
The post <a rel="nofollow" href="http://dev.globalventuringreview.com/2020/12/14-december-2020-drug-development-company-tempus-secures-200m/">14 December 2020 – Drug Development Company Tempus Secures $200m</a> appeared first on <a rel="nofollow" href="http://dev.globalventuringreview.com">CVC Unplugged</a>.

The Big Ones 2020 has been a year when, for obvious reasons, innovative drug development has taken a leap forward. Tempus combines artificial intelligence and… The post 14 December 2020 – Drug Development Company Tempus Secures $200m appeared first on CVC Unplugged.

The Big Ones 2020 has been a year when, for obvious reasons, innovative drug development has taken a leap forward. Tempus combines artificial intelligence and…
The post <a href="http://dev.globalventuringreview.com/2020/12/14-december-2020-drug-development-company-tempus-secures-200m/" rel="noopener noreferrer">14 December 2020 – Drug Development Company Tempus Secures $200m</a> appeared first on <a href="http://dev.globalventuringreview.com" rel="noopener noreferrer">CVC Unplugged</a>.

14 December 2020 – Drug Development Company Tempus Secures $200m

A look back over the past week in corporate, university and impact venturing news from all over the world. The podcast covers investments, exits, fundraising, people moves and more. Presented by James Mawson, founder and editor-in-chief of Global Corporate Venturing, and Thierry Heles, editor of Global University Venturing.

Share 14 December 2020 – Drug Development Company Tempus Secures $200m

Sign up to save your podcasts

14 December 2020 – Drug Development Company Tempus Secures $200m

14 December 2020 – Drug Development Company Tempus Secures $200m